Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient

A. Magliano; A. Cuccaro; Francesco D'Alo'; E. Maiolo; S. Bellesi; Stefan Hohaus; A. Bacigalupo; Livio Pagano

doi:10.4084/MJHID.2021.054

Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient

A. Magliano
, A. Cuccaro
, Francesco D'Alo'
, E. Maiolo
, S. Bellesi
, Stefan Hohaus
, A. Bacigalupo
, Livio Pagano

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

no abstract

Lingua originale	Inglese
pagine (da-a)	e2021054-e2021058
Numero di pagine	4
Rivista	Mediterranean Journal of Hematology and Infectious Diseases
Volume	13
Numero di pubblicazione	1
DOI	https://doi.org/10.4084/MJHID.2021.054
Stato di pubblicazione	Pubblicato - 2021

All Science Journal Classification (ASJC) codes

Ematologia
Malattie Infettive

Keywords

Bendamustine
CD4+ lymphopenia
Cytomegalovirus
Mantle cell lymphoma
Non-Hodgkin-s lymphoma

Accesso al documento

10.4084/MJHID.2021.054

Altri file e collegamenti

Cita questo

Magliano, A., Cuccaro, A., D'Alo', F., Maiolo, E., Bellesi, S., Hohaus, S., Bacigalupo, A., & Pagano, L. (2021). Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient. Mediterranean Journal of Hematology and Infectious Diseases, 13(1), e2021054-e2021058. https://doi.org/10.4084/MJHID.2021.054

@article{1a58b969e03f4e82839bf0be0b1a2d0a,

title = "Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient",

abstract = "no abstract",

keywords = "Bendamustine, CD4+ lymphopenia, Cytomegalovirus, Mantle cell lymphoma, Non-Hodgkin-s lymphoma, Bendamustine, CD4+ lymphopenia, Cytomegalovirus, Mantle cell lymphoma, Non-Hodgkin-s lymphoma",

author = "A. Magliano and A. Cuccaro and Francesco D'Alo' and E. Maiolo and S. Bellesi and Stefan Hohaus and A. Bacigalupo and Livio Pagano",

year = "2021",

doi = "10.4084/MJHID.2021.054",

language = "English",

volume = "13",

pages = "e2021054--e2021058",

journal = "Mediterranean Journal of Hematology and Infectious Diseases",

issn = "2035-3006",

publisher = "Universita Cattolica del Sacro Cuore",

number = "1",

}

Magliano, A, Cuccaro, A, D'Alo', F, Maiolo, E, Bellesi, S, Hohaus, S, Bacigalupo, A & Pagano, L 2021, 'Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient', Mediterranean Journal of Hematology and Infectious Diseases, vol. 13, n. 1, pagg. e2021054-e2021058. https://doi.org/10.4084/MJHID.2021.054

TY - JOUR

T1 - Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient

AU - Magliano, A.

AU - Cuccaro, A.

AU - D'Alo', Francesco

AU - Maiolo, E.

AU - Bellesi, S.

AU - Hohaus, Stefan

AU - Bacigalupo, A.

AU - Pagano, Livio

PY - 2021

Y1 - 2021

N2 - no abstract

AB - no abstract

KW - Bendamustine

KW - CD4+ lymphopenia

KW - Cytomegalovirus

KW - Mantle cell lymphoma

KW - Non-Hodgkin-s lymphoma

KW - Bendamustine

KW - CD4+ lymphopenia

KW - Cytomegalovirus

KW - Mantle cell lymphoma

KW - Non-Hodgkin-s lymphoma

UR - https://publicatt.unicatt.it/handle/10807/196885

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85115167434&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85115167434&origin=inward

U2 - 10.4084/MJHID.2021.054

DO - 10.4084/MJHID.2021.054

M3 - Article

SN - 2035-3006

VL - 13

SP - e2021054-e2021058

JO - Mediterranean Journal of Hematology and Infectious Diseases

JF - Mediterranean Journal of Hematology and Infectious Diseases

IS - 1

ER -

Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo